Technology
New evidence shows tirzepatide and semaglutide strongly protect the heart
2025-11-21 23:10
459 views
A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular protection—reducing heart attack, stroke, and death in adults with type 2 diabe...
A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular protection—reducing heart attack, stroke, and death in adults with type 2 diabetes. While companies have claimed large differences favoring their own medications, researchers found only modest distinctions between the two blockbuster GLP-1 drugs.
Related Articles
Wetherspoon to make international debut with first ever pub in mainland Europe
509 views
Google's new AirDrop feature is great for Pixel phones – but it can’t chase Apple’s tail forever
939 views
Facing facts on property tax: Rachel Reeves’s Budget options as she hunts for billions
509 views
Unexpected Ways To Use Your DeWalt Tools (According To Owners)
510 views